KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Immuneering Corporation stock price on Thursday moving 10.20% between high and low
(Updated on Apr 25, 2024)

Sell candidate since Mar 11, 2024 Loss -75.91% PDF

The Immuneering Corporation stock price fell by -4.67% on the last day (Thursday, 25th Apr 2024) from $1.50 to $1.43. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 10.20% from a day low at $1.40 to a day high of $1.54. The price has fallen in 7 of the last 10 days and is down by -31.25% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -95 thousand shares and in total, 375 thousand shares were bought and sold for approximately $536.23 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.49 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMRX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Immuneering Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.67 and $2.78. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -50.52%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Immuneering Corporation stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.143 between high and low, or 10.20%. For the last week the stock has had daily average volatility of 10.62%.

Immuneering Corporation is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IMRX) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Immuneering Corporation to open at $1.46, and during the day (based on 14 day Average True Range), to move between $1.16 and $1.70, which gives a possible trading interval of +/-$0.274 (+/-19.16%) up or down from last closing price. If Immuneering Corporation takes out the full calculated possible swing range there will be an estimated 38.32% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.50, some $0.0700 (4.90%) from the current price of $1.43, our system finds the risk reward not very attractive.

Earnings coming up

Immuneering Corporation will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.450. We will update the financials statements for Immuneering Corporation, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.12% in the first trading day after earnings release.

Is Immuneering Corporation stock A Buy?

Immuneering Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.244 Strong Sell Candidate Unchanged

Predicted Opening Price for Immuneering Corporation of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$1.46 ( 1.93%) $1.43

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.60 11.92 %
R2 1.55 8.10 %
R1 1.51 5.74 %
Current price: 1.43
Support S1 1.40 -1.88 %
S2 1.37 -4.24 %
S3 1.31 -8.06 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.72 20.28 %
R2 1.63 13.99 %
R1 1.50 4.90 %
Current price 1.43
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Immuneering Corporation Stock and on which exchange is it traded?
The symbol for Immuneering Corporation is IMRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Immuneering Corporation Stock?
Immuneering Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Immuneering Corporation Stock?
Immuneering Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immuneering Corporation Stock.

What's the current price of Immuneering Corporation Stock?
As of the end of day on the Apr 25, 2024, the price of an Immuneering Corporation (IMRX) share was $1.43.

What is the 52-week high and low for Immuneering Corporation Stock?
The 52-week high for Immuneering Corporation Stock is $11.92 and the 52-week low is $1.40.

What is the market capitalization of Immuneering Corporation Stock?
As of the Apr 25, 2024, the market capitalization of Immuneering Corporation is 41.875M.

When is the next earnings date for Immuneering Corporation?
The upcoming earnings date for Immuneering Corporation is May 02, 2024.
Click to get the best stock tips daily for free!

About Immuneering Corporation

Immuneering Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed ... IMRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT